Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol regulatory element-binding protein 1 (SREBP-1) is a key transcription factor that regulates the expression of genes involved in lipid biosynthesis, including fatty acid, triglyceride, and cholesterol synthesis. It plays a central role in maintaining lipid homeostasis and is implicated in various metabolic diseases, including obesity, type II diabetes mellitus, and non-alcoholic fatty liver disease. Upregulated activity also supports tumor cell growth. There are two major isoforms, SREBP-1a and SREBP-1c, which differ in their tissue distribution and specific functions in lipid metabolism.
SREBP-1 is a transcription factor that binds to sterol regulatory elements (SREs) within promoters of target genes to regulate their expression. Drugs can target the activation/cleavage process, nuclear translocation, or DNA binding activity of SREBP-1 to modulate lipid metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol Regulatory Element-Binding Protein 1 (SREBP-1).